Related Experiment Video
Updated: Aug 17, 2026

Examining BCL-2 Family Function with Large Unilamellar Vesicles
Published on: October 5, 2012
Mutation of BCL-2 Family Proteins in Cancer
1Ludwig Institute for Cancer Research and Virology and Cell Biology, Department of Medical Microbiology, Imperial College School of Medicine at St Mary's, Norfolk Place, London, W2 1PG, UK. g.packham@ic.ac.uk
Abstract:
Apoptosis is a genetically controlled cell death process that is required for normal development and tissue homeostasis. Suppression of apoptosis can confer a growth advantage to cells and contribute to cancer; many cancers are relatively resistant to apoptosis, including that induced by radiation or chemotherapeutics. Mutations which inactivate pro-apoptotic or activate anti-apoptotic proteins in cancer cells are therefore likely to be responsible for some of these differences. BCL-2 family proteins are key regulators of apoptosis and there is evidence supporting a role for mutation of BCL-2 family proteins in cancer. This includes well established events such as activation of BCL-2 via translocations in follicular lymphoma, as well as more recent observations implicating activation of Bcl-X(L) expression and frameshift and missense mutations of BAX and BCL-2 in cancer.
Insights
Apoptosis, a programmed cell death, is crucial for development. Its suppression aids cancer growth, with BCL-2 family mutations playing a key role in cancer development and resistance.
Area of Science:
- Cell Biology
- Oncology
- Genetics
Background:
- Apoptosis is a genetically regulated process vital for development and tissue balance.
- Cancer cells often evade apoptosis, contributing to tumor growth and resistance to therapies.
- Dysregulation of apoptosis, particularly involving BCL-2 family proteins, is implicated in various cancers.
Purpose of the Study:
- To explore the role of BCL-2 family protein mutations in cancer.
- To understand how apoptosis suppression contributes to cancer development and progression.
Main Methods:
- Review of existing literature on apoptosis regulation and cancer genetics.
- Analysis of genetic alterations in BCL-2 family genes (BCL-2, BAX, Bcl-X(L)) in cancer.
Main Results:
- Mutations inactivating pro-apoptotic or activating anti-apoptotic proteins are linked to cancer.
- Specific examples include BCL-2 activation via translocations in follicular lymphoma.
- Frameshift and missense mutations in BAX and BCL-2 are observed in cancers.
Conclusions:
- BCL-2 family proteins are critical regulators of apoptosis and their mutations are significant in cancer.
- Understanding these mutations is key to developing targeted cancer therapies.
Related Concept Videos
Abnormal Proliferation
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Intrinsic Apoptotic Pathway
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

